Bladder cancer is one of the more common forms of cancer. According to the Centers for Disease Control and Prevention, about 57,000 men and 8,000 women are diagnosed with bladder cancer annually, and roughly 12,000 men and 4,700 women die from the disease each year in the US.
Most newly diagnosed bladder cancers (75% to 80%) are classified as NMIBC, where cancer cells grow through the lining of the bladder but have not yet invaded the muscle layer. NMIBC is associated with high rates of recurrence (between 30% and 80%) and a risk of progression to invasive and metastatic cancer.
